NASDAQ

Fulgent Genetics, Inc. (FLGT)

603 Thanks from members

Fulgent Genetics exhibits a mixed sentiment profile characterized by strong balance sheet support, asset integration tailwinds, and aggressive share repurchases, offset by widening GAAP losses, billing-system disruptions, and lowered 2026 revenue guidance.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →